Evidence map›Paper›PMID 29980699›Full record

ArticleScientific reports2018

Diversity among bla

Tracy H Hazen, Roberta Mettus, Christi L McElheny, Sarah L Bowler, Sushma Nagaraj, Yohei Doi, David A Rasko

Abstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Role of Mobilome in Carbapenem Resistance.Antibiotics (Basel, Switzerland) · 2026
    Review
  2. First report of anMicrobiology spectrum · 2026
    Article
  3. Article
  4. Review
  5. Identification and evolution of novelMicrobiology spectrum · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Plasmid genomic epidemiology ofAntimicrobial agents and chemotherapy · 2023
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Within patient genetic diversity of blaScientific reports · 2021
    Article
  17. Genomic data reveals the emergence of an IncQ1 small plasmid carrying blaJournal of global antimicrobial resistance · 2021
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tracy H HazenInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Roberta MettusDivision of Infectious Diseases and Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Christi L McElhenyDivision of Infectious Diseases and Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sarah L BowlerDivision of Infectious Diseases and Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sushma NagarajInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA.
Yohei DoiDivision of Infectious Diseases and Center for Innovative Antimicrobial Therapy, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. yod4@pitt.edu.
David A RaskoInstitute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, 21201, USA. drasko@som.umaryland.edu.ORCID 0000-0002-7337-7154

Funding

Technology CoreU19AI110820 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI WHITE, OWEN R · 2014 to 2023
$36.5M
Colistin-resistant Acinetobacter baumanniiR01AI104895 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI, ERNST, ROBERT K · 2014 to 2024
$4.2M
Mechanisms and implications of fosfomycin resistance in Escherichia coliR21AI123747 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DOI, YOHEI · 2016 to 2017
$417k
NIAID NIH HHS R01 AI104895NIAID NIH HHS R21 AI123747NIAID NIH HHS U19 AI110820
6 · The paper itself

Abstract

Carbapenem resistant Enterobacteriaceae are a significant public health concern, and genes encoding the Klebsiella pneumoniae carbapenemase (KPC) have contributed to the global spread of carbapenem resistance. In the current study, we used whole-genome sequencing to investigate the diversity of bla

Indexed as

Anti-Bacterial AgentsBacteriaBacterial InfectionsBacterial Proteinsbeta-LactamasesDrug Resistance, BacterialEscherichia coliEscherichia coli InfectionsGenome, BacterialHumansPlasmidsAnti-Bacterial AgentsBacterial Proteinsbeta-Lactamasescarbapenemase

Identifiers

PMID29980699
PMCPMC6035167

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.